The sickle cell disease burden in west Africa is among the highest in the world.
Articles on sickle cell disease
Displaying all articles
Following the controversial births of the first gene-edited babies, a major focus of the Third International Summit on Human Genome Editing was responsible use of CRISPR.
Gene editing promises everything from treatments for serious conditions like sickle cell disease to the resurrection of the dodo.
Of the 20 million people living with sickle cell disease globally, more than 66% are in sub-Saharan Africa.
New payment models may mean more of the people who need these treatments can get them.
Scientists have been eager to edit genomes to eliminate certain diseases. New WHO reports outlines ethical approaches to research and treatment.
Evolutionary medicine uses our ancestral history to explain disease prevalence and inform care for conditions like Type 2 diabetes. It also challenges the bio-ethnocentrism of western medicine.
Top contributors
-
Professor, Applied Evolutionary Ecology, Laurentian University
-
Graduate Student - Department of Psychology, Laurentian University
-
Professor of Bioinformatics, Rochester Institute of Technology
-
Senior lecturer in Haematology, University of Ghana
-
Postdoctoral Fellow, Faculty of Health Sciences, McMaster University
-
Senior Lecturer in Biomedical Sciences, Anglia Ruskin University
-
Director General, National Institute for Pharmaceutical Research and Development
-
Dean of the College of Science, Professor of Biochemistry, Rochester Institute of Technology
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Postdoctoral Fellow in Precision Medicine and Emerging Biotechnologies, Arizona State University
-
Associate professor, Medicine, University of Cape Town